SCHEMBL7835513

SCHEMBL7835513

COc1cccc2c1[C@@H]1CNC[C@H]1CO2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.37
HTR1A P08908 6/20 0.36
DRD2 P14416 1/20 0.36
DRD1 P21728 1/20 0.36
HTR1B P28222 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ADRA1D P25100 4/20 0.34
ADRA1A P35348 4/20 0.34
ADRA1B P35368 4/20 0.34
ALDH1A1 P00352 2/20 0.34
CYP3A4 P08684 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6218189 1.00 CYP19A1 (0.37) CYP19A1HTR1ADRD2DRD1HTR1B
SCHEMBL6218185 1.00 CYP19A1 (0.37) CYP19A1HTR1ADRD2DRD1HTR1B
SCHEMBL7835510 1.00 CYP19A1 (0.37) CYP19A1HTR1ADRD2DRD1HTR1B
SCHEMBL6218182 1.00 CYP19A1 (0.37) CYP19A1HTR1ADRD2DRD1HTR1B
Hydrochloric Acid SCHEMBL8685813 0.99 CYP19A1 (0.36) CYP19A1HTR1ADRD2DRD1HTR1B
Hydrochloric Acid SCHEMBL8903134 0.99 CYP19A1 (0.36) CYP19A1HTR1ADRD2DRD1HTR1B
Hydrochloric Acid SCHEMBL8684946 0.99 CYP19A1 (0.36) CYP19A1HTR1ADRD2DRD1HTR1B
SCHEMBL7844867 0.88 HTR2C (0.38) CYP19A1HTR1AHTR2CCYP2D6ADRA2C
SCHEMBL7844871 0.88 HTR2C (0.38) CYP19A1HTR1AHTR2CCYP2D6ADRA2C
SCHEMBL1802487 0.86 MAP3K14 (0.39) HTR1AHTR2CADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0942911-B1 BENZOPYRANOPYRROLE AND BENZOPYRANOPYRIDINE ALPHA-1 ADRENERGIC COMPOUNDS ABBOTT LAB (US) 2001-10-17 EP disclosed
US-6046207-A FOR INHIBITING ALPHA-1 ADRENORECEPTORS AND TREATING BENIGN PROSTATIC HYPERPLASIA, ALSO CALLED BENIGN PROSTATIC HYPERTROPHY, OR OTHER UROLOGICAL OR GYNECOLOGICAL DISEASES SUCH AS BLADDER OUTLET OBSTRUCTION, NEUROGENIC BLADDER ABBOTT LABORATORIES 2000-04-04 US disclosed
US-5891882-A TREATING BENIGN PROSTATIC HYPERPLASIA OR OTHER UROLOGICAL DISEASES SUCH AS BLADDER OUTLET OBSTRUCTION AND NEUROGENIC BLADDER, OR GYNECOLOGICAL SYNDROMES SUCH AS DYSMENORRHEA ABBOTT LABORATORIES (US) 1999-04-06 US disclosed